Your browser doesn't support javascript.
loading
A Phase 1/2 Trial of Brief Androgen Suppression and Stereotactic Radiation Therapy (FASTR) for High-Risk Prostate Cancer.
Bauman, Glenn; Ferguson, Michelle; Lock, Michael; Chen, Jeff; Ahmad, Belal; Venkatesan, V M; Sexton, Tracy; D'Souza, David; Loblaw, Andrew; Warner, Andrew; Rodrigues, George.
Afiliación
  • Bauman G; Division of Radiation Oncology, Department of Oncology, Western University and London Regional Cancer Program, London, Ontario, Canada. Electronic address: Glenn.bauman@lhsc.on.ca.
  • Ferguson M; Department of Radiation Oncology, Allan Blair Cancer Centre, Regina, Saskatchewan, Canada.
  • Lock M; Division of Radiation Oncology, Department of Oncology, Western University and London Regional Cancer Program, London, Ontario, Canada.
  • Chen J; Division of Radiation Oncology, Department of Oncology, Western University and London Regional Cancer Program, London, Ontario, Canada.
  • Ahmad B; Division of Radiation Oncology, Department of Oncology, Western University and London Regional Cancer Program, London, Ontario, Canada.
  • Venkatesan VM; Division of Radiation Oncology, Department of Oncology, Western University and London Regional Cancer Program, London, Ontario, Canada.
  • Sexton T; Division of Radiation Oncology, Department of Oncology, Western University and London Regional Cancer Program, London, Ontario, Canada.
  • D'Souza D; Division of Radiation Oncology, Department of Oncology, Western University and London Regional Cancer Program, London, Ontario, Canada.
  • Loblaw A; Department of Radiation Medicine, University of Toronto and Odette Cancer Center, Toronto, Ontario, Canada.
  • Warner A; Division of Radiation Oncology, Department of Oncology, Western University and London Regional Cancer Program, London, Ontario, Canada.
  • Rodrigues G; Division of Radiation Oncology, Department of Oncology, Western University and London Regional Cancer Program, London, Ontario, Canada.
Int J Radiat Oncol Biol Phys ; 92(4): 856-62, 2015 Jul 15.
Article en En | MEDLINE | ID: mdl-25936597
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Hormona Liberadora de Gonadotropina / Antagonistas de Andrógenos Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Int J Radiat Oncol Biol Phys Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Hormona Liberadora de Gonadotropina / Antagonistas de Andrógenos Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Int J Radiat Oncol Biol Phys Año: 2015 Tipo del documento: Article